Metabolic imaging: The role of imaging in risk evaluation of ischemic heart disease

Mark T. Harbinson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


In ischemic heart disease (IHD), understanding the pathophysiology, and relating this to prognosis, are of prime importance. Many important physiological parameters have been shown to be closely related to patient outcome in IHD. Myocardial perfusion, myocardial cell viability, left ventricular function, response of dysfunctional myocardium to revascularization, and cardiac sympathetic innervation represent important metabolic targets in such patients. Nuclear imaging techniques utilizing radioisotopes designed to probe these processes have advanced our understanding of the underlying pathophysiology of IHD, and have provided robust markers of risk and prognosis suitable for use in routine clinical practice.

Original languageEnglish
Pages (from-to)15-18
Number of pages4
JournalHeart and Metabolism
Issue number36
Publication statusPublished - 01 Jan 2007


  • Ischemic heart disease
  • Metabolic tracers
  • Myocardial perfusion imaging
  • Nuclear cardiology
  • Prognosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Metabolic imaging: The role of imaging in risk evaluation of ischemic heart disease'. Together they form a unique fingerprint.

Cite this